PARADIGM
"PARADIGM" is a word mark owned by Paradigm Health, Inc., filed at the USPTO on September 8, 2022. It has been allowed and covers classes 9, 35 and 42.
- Status
- Allowed
- Since October 6, 2026
- Filed
- September 8, 2022
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 97583445
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns PARADIGM
The owner and representative on file with the office.
Owner
Paradigm Health, Inc.
Columbus, United States
Representative
Perry J. Viscounty
Latham & Watkins LLP
What the mark covers
The products and services PARADIGM is filed for, grouped by Nice class.
Downloadable computer programs, and mobile device software for use by recruiting sites, principal investigators, clinical care teams, and/or patients for clinical trials, for use in planning, designing, implementing and/or managing clinical trials, and for use in conducting research, including patient journey analyses, cohort segmentation analysis, clinical trial design analysis, patient and population risk stratification analysis, safety and efficacy analysis, and/or health economics and outcomes research for clinical trials; application program interfaces, namely, downloadable software enabling software components to interact with each other for clinical trials
Business consulting and management in the field of data analytics for medical clinical trials, namely, management and compilation of databases in the field of medical clinical trials for business purposes; business consulting and management in the field of data analytics for medical clinical trials, namely, providing business information management services for such clinical trials; business information management in the field of data analytics for care coordination, and care navigation services in coordination with and/or on behalf of health plans, clinical trial sponsors, pharmaceutical manufacturers, physicians, hospital systems, patient advocacy organizations and/or other medical providers, all the foregoing in connection with medical clinical trials
Providing temporary use of online, non-downloadable software for use by principal investigators, recruiting sites, clinical care teams, and/or patients for clinical trials, for use in planning, designing, implementing and/or managing clinical trials and for use in conducting research, namely, patient journey analyses, cohort segmentation analysis, clinical trial design analysis, patient and population risk stratification analysis in connection with medical clinical trials, safety and efficacy analysis in connection with medical clinical trials, health economics and outcomes research, and/or comparative effectiveness analyses in connection with medical clinical trials; application service provider featuring application programming interface software for enabling software components to interact with each other in connection with medical clinical trials; providing use of online, non-downloadable software to health care providers for patient evaluation, care navigation, quality improvement, and clinical research in connection with medical clinical trials; providing use of online, non-downloadable software to health care providers, patients, advocacy organizations, and/or other parties involved in patient care to support the design, start up, conduct, and/or analysis of medical clinical trials; software as a service (SaaS) solutions featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing medical clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing data analytics for medical and scientific research information in the field of pharmaceuticals and clinical trials; providing data analytics for scientific research for medical purposes in connection with medical clinical trials; clinical trial support services in connection with data analytics, namely data analytics for scientific research in the nature of coordinating medical clinical trial research for others; virtual consulting services in connection with data analytics for medical and scientific research related to clinical trials
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Noa e-mailed - sou required from applicant
- Ttab release case to trademarks
- Opposition terminated no. 999999
- Opposition dismissed no. 999999
- Extension of time to oppose process - terminated
- Opposition instituted no. 999999
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About PARADIGM
Who owns the trademark "PARADIGM"?
The USPTO trademark "PARADIGM" (application 97583445) is owned by Paradigm Health, Inc.
What is the status of "PARADIGM"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull PARADIGM and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2aed-4626-751c-b415-2c1e47343948
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2aed-4626-751c-b415-2c1e47343948",
"object": "trademark",
"mark_text": "PARADIGM",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "97583445",
"filing_date": "2022-09-08",
"nice_classes": [
9,
35,
42
],
"owners": [
{
"name": "PARADIGM HEALTH, INC.",
"entity_id": null
}
]
}